These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 343993)

  • 1. Comparison of 0.1% halcinonide with 0.05% betamethasone dipropionate in the treatment of acute and chronic dermatoses.
    Levy A
    Curr Med Res Opin; 1977-1978; 5(4):328-32. PubMed ID: 343993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind comparison between two new topical corticosteroids, halcinonide 0.1% and clobetasol propionate cream 0.05%.
    Bleeker J
    Curr Med Res Opin; 1975; 3(4):225-8. PubMed ID: 1097198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Halcinonide, a new topical anti-inflammatory steroid.
    Savin RC
    J Int Med Res; 1976; 4(1):34-6. PubMed ID: 799976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of halcinonide and fluocinonide creams in psoriasis and eszematous dermatoses.
    Sudilovsky A; Clewe TH
    J Clin Pharmacol; 1975; 15(11-12):779-84. PubMed ID: 1104668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind comparison of the efficacy of betamethasone dipropionate cream twice daily versus once daily in the treatment of steroid responsive dermatoses.
    English JS; Bunker CB; Ruthven K; Dowd PM; Greaves MW
    Clin Exp Dermatol; 1989 Jan; 14(1):32-4. PubMed ID: 2680178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Halcinonide in the treatment of corticosteroid responsive dermatoses.
    Leibsohn E; Bagatell FK
    Br J Dermatol; 1974 Apr; 90(4):435-40. PubMed ID: 4596068
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative clinical evaluation of a new topical steroid 'halcinonide' and hydrocortisone in steroid-responsive dermatoses.
    Fattah AA; El-Shiemy S; Faris R; Tadros SS
    J Int Med Res; 1976; 4(4):228-31. PubMed ID: 1026547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind comparison of halcinonide and betamethasone valerate. Use with occlusive dressings in psoriasis treatment.
    Clark RF; Clement ER
    Arch Dermatol; 1975 Jun; 111(6):731-3. PubMed ID: 1094960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic uses of halcinonide.
    Beveridge GW
    Scott Med J; 1977 Jul; 22(3):231-3. PubMed ID: 329412
    [No Abstract]   [Full Text] [Related]  

  • 10. Double-blind paired comparison clinical trial of halcinonide and hydrocortisone.
    el-Hefnawi H; el-Shiemy S; Paris R; Tadros SS
    Cutis; 1978 Jul; 22(1):97-9. PubMed ID: 352631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparison of a new combination (halcinonide-neomycin-amphotericin) and active controls in cutaneous candidiasis and steroid-responsive dermatoses.
    Abdel-Aal H; Abdel-Fattah A; Shiemy S; Faris R; Tadros SS
    J Int Med Res; 1976; 4(4):232-6. PubMed ID: 799995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of erythrosquamous dermatoses. Betamethasone dipropionate plus salicylic acid in comparison with betamethasone dipropionate solution].
    Nolting S; Hagemeier HH
    Fortschr Med; 1983 Oct; 101(37):1679-83. PubMed ID: 6227542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical halcinonide and betamethasone valerate effects on plasma cortisol: acute and subacute usage studies.
    Gomez EC; Kaminester L; Frost P
    Arch Dermatol; 1977 Sep; 113(9):1196-202. PubMed ID: 332089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic side-effects of three topical steroids in diseased skin.
    Salde L; Lassus A
    Curr Med Res Opin; 1983; 8(7):475-80. PubMed ID: 6226490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind controlled trial of betamethasone dipropionate 0.05% (Diproderm) in comparison with fluocinolone acetonide 0.025% (Synalar) in psoriasis and other steroid-responsive dermatoses.
    Afzelius HW; Jacobsen KU
    J Int Med Res; 1979; 7(5):411-4. PubMed ID: 387495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical mometasone. A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders.
    Prakash A; Benfield P
    Drugs; 1998 Jan; 55(1):145-63. PubMed ID: 9463794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind comparison of halcinonide solution and placebo control in treatment of psoriasis of the scalp.
    Lepaw MI
    Cutis; 1978 Apr; 21(4):571-3. PubMed ID: 346315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent topical treatment of psoriasis with betamethasone dipropionate 0.05 percent cream.
    van Dijk E; Bakkers EJ; Go MJ; Montnor LP; Roessel FE; van der Wateren AR; Wuite J
    Cutis; 1983 Sep; 32(3):284-5, 287. PubMed ID: 6354613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of halcinonide cream, 0.1 percent, in the treatment of moderate and severe dermatoses.
    Belknap BS; Dobson RL
    Cutis; 1981 Apr; 27(4):433-5. PubMed ID: 7226895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a topical steroid antibiotic combination (halcinonide-neomycin-amphotericin) in the treatment of cutaneous candidiasis and inflammatory dermatoses.
    Theodoridis A; Vagena A; Sivenas C; Capetanakis J
    Curr Med Res Opin; 1979; 5(10):766-71. PubMed ID: 155507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.